SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012350
Filing Date
2019-08-14
Accepted
2019-08-14 11:04:30
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 785149
2 ex31-1.htm EX-31.1 37135
3 ex32-1.htm EX-32.1 9067
  Complete submission text file 0001493152-19-012350.txt   3794246

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE imun-20190630.xml EX-101.INS 662899
5 XBRL SCHEMA FILE imun-20190630.xsd EX-101.SCH 48256
6 XBRL CALCULATION FILE imun-20190630_cal.xml EX-101.CAL 48299
7 XBRL DEFINITION FILE imun-20190630_def.xml EX-101.DEF 155848
8 XBRL LABEL FILE imun-20190630_lab.xml EX-101.LAB 285703
9 XBRL PRESENTATION FILE imun-20190630_pre.xml EX-101.PRE 230123
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 191023965
SIC: 2834 Pharmaceutical Preparations